These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13704051)

  • 1. [Considerations on various aspects of water elimination in ascitogenous liver cirrhosis].
    GAVRILESCU S; STREIAN C; OCICA I
    Med Interna (Bucur); 1961 Jun; 13():933-45. PubMed ID: 13704051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diuretic effect of spironolactone (Sc-9420) in patients with cirrhosis of the liver with ascites].
    RIVERA A; SEPULVEDA B; LANDA L; CHAGOYA L
    Rev Med Chil; 1961 Oct; 89():843-6. PubMed ID: 14038707
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of the hydrosaline retention in hepatic cirrhosis with spironolactone].
    VELASCO M; GAZMURI R; KATZ R
    Rev Med Chil; 1961 Oct; 89():846-51. PubMed ID: 13925219
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ascites caused by portal stasis: my experience with the use of mercurial diuretics injected directly into the ascites fluid].
    AGOSTONI G
    Med Contemp; 1962 Feb; 80():77-82. PubMed ID: 13859631
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on portal hypertension and ascites in Egyptian cirrhotics I. The effect of diuretics.
    EL-ROOBY A; ATA AA; DANASOURY M; EL-RAZEKKI E
    J Egypt Med Assoc; 1961; 44():629-44. PubMed ID: 14489533
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comments on the use of spirolactones in the treatment of ascitic cirrhosis (5 cases)].
    GRILLIAT JP; MARCHAL C; ANTOINE ; SAPELIER P; KIFFER B
    Rev Med Nancy; 1961; 86():801-20. PubMed ID: 13901929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Spirolactones in the treatment of ascitogenic hepatic cirrhosis. Clinical and biological effects].
    BONINI A
    Minerva Med; 1962 Jun; 53():1990-4. PubMed ID: 13871015
    [No Abstract]   [Full Text] [Related]  

  • 8. The management of ascites and hyponatremia in cirrhosis.
    Ginès P; Cárdenas A
    Semin Liver Dis; 2008 Feb; 28(1):43-58. PubMed ID: 18293276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical aspects and therapy of ascites. Complications of therapy].
    Pannacciulli I
    Minerva Med; 1987 May; 78(10):663-7. PubMed ID: 3587713
    [No Abstract]   [Full Text] [Related]  

  • 11. [Association of the diuretic actions of delta-cortisone and spirolactone in the treatment of cirrhotic edema].
    VESIN P; CATTAN R
    Bull Mem Soc Med Hop Paris; 1960 Oct 14-21; 76():1005-12. PubMed ID: 13781048
    [No Abstract]   [Full Text] [Related]  

  • 12. [New diuretics in ascites of the cirrhotic patient (dihydroflumethiazide, benzhydroflumethiazide)].
    PIZZUTO J; DIES F; RIVERA A
    Prensa Med Mex; 1960 Jul 30-Sep 30; 25():394-404. PubMed ID: 13736169
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electrolyte development of ascitogenous liver cirrhosis].
    NUNEZ CARRIL J; SALMERON M; TORREGROSA JM; SANCHEZ AGESTA A; ORTIZ DE LANDAZURI E
    Rev Clin Esp; 1957 Aug; 66(3):164-74. PubMed ID: 13506163
    [No Abstract]   [Full Text] [Related]  

  • 14. [Functional renal insufficiency in patients with ascitic cirrhosis. Critical study of the role of diuretics].
    VESIN P; RUEFF B; TRAVERSO H; HIRSCH-MARIE H; CATTAN R
    Bull Mem Soc Med Hop Paris; 1962; 113():787-95. PubMed ID: 13925631
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of ascitis in patients with cirrhosis].
    Arfaoui D; Ajmi S
    Tunis Med; 2007 Feb; 85(2):91-5. PubMed ID: 17665651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A; Terra C; Guevara M; Ginès P
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of ascites and hepatic hydrothorax.
    Cárdenas A; Arroyo V
    Best Pract Res Clin Gastroenterol; 2007; 21(1):55-75. PubMed ID: 17223497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular and extracellula fluid and electrolyte alterations in cirrhosis of the liver with edema and ascites.
    STRUB IH; TALSO PJ; KIRSNER JB
    Gastroenterology; 1955 Feb; 28(2):163-75; discussion, 176-82. PubMed ID: 14353272
    [No Abstract]   [Full Text] [Related]  

  • 20. [2 Non alcoholic cirrhotic ascites cured with cortisone and metacortandracin].
    CORCOS A; CORCOS S; LEVI-ABEGNOLI J
    Bull Mem Soc Med Hop Paris; 1956; 72(27-28):915-8. PubMed ID: 13396598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.